Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome

Detalles Bibliográficos
Autores principales: Goyal, Amrita, Narayanan, Damodaran, Wong, Waihay, Laga, Alvaro C., Connell, Nathan T., Ritter, Susan Y., Cobos, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980309/
https://www.ncbi.nlm.nih.gov/pubmed/35391910
http://dx.doi.org/10.1016/j.jdcr.2022.02.022
_version_ 1784681361601200128
author Goyal, Amrita
Narayanan, Damodaran
Wong, Waihay
Laga, Alvaro C.
Connell, Nathan T.
Ritter, Susan Y.
Cobos, Gabriela
author_facet Goyal, Amrita
Narayanan, Damodaran
Wong, Waihay
Laga, Alvaro C.
Connell, Nathan T.
Ritter, Susan Y.
Cobos, Gabriela
author_sort Goyal, Amrita
collection PubMed
description
format Online
Article
Text
id pubmed-8980309
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89803092022-04-06 Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome Goyal, Amrita Narayanan, Damodaran Wong, Waihay Laga, Alvaro C. Connell, Nathan T. Ritter, Susan Y. Cobos, Gabriela JAAD Case Rep Case Report Elsevier 2022-03-02 /pmc/articles/PMC8980309/ /pubmed/35391910 http://dx.doi.org/10.1016/j.jdcr.2022.02.022 Text en © 2022 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Goyal, Amrita
Narayanan, Damodaran
Wong, Waihay
Laga, Alvaro C.
Connell, Nathan T.
Ritter, Susan Y.
Cobos, Gabriela
Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
title Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
title_full Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
title_fullStr Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
title_full_unstemmed Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
title_short Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
title_sort tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, e1 enzyme, x-linked, autoinflammatory, somatic (vexas) syndrome without myelodysplastic syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980309/
https://www.ncbi.nlm.nih.gov/pubmed/35391910
http://dx.doi.org/10.1016/j.jdcr.2022.02.022
work_keys_str_mv AT goyalamrita tocilizumabfortreatmentofcutaneousandsystemicmanifestationsofvacuolese1enzymexlinkedautoinflammatorysomaticvexassyndromewithoutmyelodysplasticsyndrome
AT narayanandamodaran tocilizumabfortreatmentofcutaneousandsystemicmanifestationsofvacuolese1enzymexlinkedautoinflammatorysomaticvexassyndromewithoutmyelodysplasticsyndrome
AT wongwaihay tocilizumabfortreatmentofcutaneousandsystemicmanifestationsofvacuolese1enzymexlinkedautoinflammatorysomaticvexassyndromewithoutmyelodysplasticsyndrome
AT lagaalvaroc tocilizumabfortreatmentofcutaneousandsystemicmanifestationsofvacuolese1enzymexlinkedautoinflammatorysomaticvexassyndromewithoutmyelodysplasticsyndrome
AT connellnathant tocilizumabfortreatmentofcutaneousandsystemicmanifestationsofvacuolese1enzymexlinkedautoinflammatorysomaticvexassyndromewithoutmyelodysplasticsyndrome
AT rittersusany tocilizumabfortreatmentofcutaneousandsystemicmanifestationsofvacuolese1enzymexlinkedautoinflammatorysomaticvexassyndromewithoutmyelodysplasticsyndrome
AT cobosgabriela tocilizumabfortreatmentofcutaneousandsystemicmanifestationsofvacuolese1enzymexlinkedautoinflammatorysomaticvexassyndromewithoutmyelodysplasticsyndrome

Ejemplares similares